Article
Enhancing Biomarker-Based Oncology Trial Matching Using Large Language Models
2024-09-19
Abstract excerpt
Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patient’s eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers are especially important in precision medicine and targeted therapies, making them essential for matching patients to appropriate trials. Large language models (LLMs) offer a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 867b8d43-9dc1-56eb-bbf6-1f4dc9d4cfde
- DOI
- 10.1101/2024.09.13.612922
